Magic mushroom drug psilocybin reduced depressive symptoms in trial
18 May 2016 | By Katie Sadler
A trial funded by the Medical Research Council has found psilocybin, the active ingredient in magic mushrooms, reduced depressive symptoms.
List view / Grid view
News
Experimental hepatitis C drug slows Zika virus infection in mice
17 May 2016 | By Katie Sadler
Virologists have discovered that an antiviral drug against hepatitis C has helped slow down the development of Zika virus in Mice.
Brain cells that play a crucial role in appetite identified
13 May 2016 | By Victoria White, Digital Content Producer
Scientists have identified cells, NG2-glia, that play a crucial role in appetite and weight gain - a discovery that could lead to anti-obesity treatments...
Breast cancer drug suppresses dangerous brain seizures
13 May 2016 | By Victoria White, Digital Content Producer
Scientists also found that inhibiting oestrogen synthesis just after seizure onset strongly suppressed seizures in both sexes...
PTSD linked to low levels of adiponectin
12 May 2016 | By Victoria White, Digital Content Producer
The UT Health Science Centre at San Antonio has filed for patent protection on the finding because it may eventually lead to a drug to treat PTSD...
Identifying targets in MYC-driven triple-negative breast cancer
12 May 2016 | By Victoria White, Digital Content Producer
Dr Andrei Goga of UC San Francisco has taken a multi-faceted approach to identifying new therapeutic targets in MYC-driven triple-negative breast cancers...
Mouse models show how Zika migrates into the placenta
11 May 2016 | By Victoria White, Digital Content Producer
In the models, the Zika virus was observed migrating from the bloodstream into the placenta, where it multiplied...
Pfizer awards more than $1 million to fund metastatic breast cancer research
11 May 2016 | By Victoria White, Digital Content Producer
Pfizer has awarded a total of more than $1 million in funding to five leading advocacy organisations to support metastatic breast cancer scientific research...
HuMiX – the new human microbiome research tool
11 May 2016 | By Victoria White, Digital Content Producer
Scientists have proven that a model of the human gut - HuMiX - is representative of the actual conditions and processes that occur within our intestines...
LDC and Boehringer Ingelheim join forces to discover schizophrenia treatment
11 May 2016 | By Victoria White, Digital Content Producer
Boehringer Ingelheim will have the option of exclusive rights to a new compound for the treatment of schizophrenia to be discovered and developed at the LDC...
Targaprimir-96 successfully targets breast cancer RNA
10 May 2016 | By Victoria White, Digital Content Producer
Scientists have designed a drug candidate, Targaprimir-96, that decreases the growth of tumour cells in animal models of triple negative breast cancer...
Designing therapeutic warheads that target cancer cells
10 May 2016 | By Victoria White, Digital Content Producer
Scientists have designed dozens of molecular “warheads” that can detect a key biomarker of cancer and could be developed into a new class of drug candidates...
Autism model offers insights to possible drug targets
10 May 2016 | By Victoria White, Digital Content Producer
A new mouse model of a genetically-linked type of autism, developed by scientists at Duke Health, reveals more about the role of genes in the disorder...
Intraocular therapy prevents or reverses diabetic retinopathy
10 May 2016 | By Victoria White, Digital Content Producer
Researchers have described a potential new intraocular treatment that prevents and reverses some characteristics of diabetic retinopathy in a mouse model...
Therapy stops treatment-resistant glioblastoma and high-grade gliomas
9 May 2016 | By Victoria White, Digital Content Producer
In laboratory tests on human cells and mouse models, an experimental therapy was shown to stop treatment-resistant glioblastoma and high-grade gliomas...